Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Director/PDMR Shareholding

6 Nov 2017 16:48

RNS Number : 7089V
ABCAM Plc
06 November 2017
 

For immediate release

6 November 2017

ABCAM PLC

("Abcam" or the "Company")

Director/PDMR Shareholding Notification

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, on 3 November 2017 granted share awards in the form of nil cost options or conditional shares ("Awards") to the following Directors/PDMRs under the Abcam plc Long Term Incentive Plan ("LTIP"):

 

PDMR

Number of 0.2 pence Ordinary Shares subject to the Awards

 

 

Alan Hirzel

Chief Executive Officer

 

60,294*

 

Gavin Wood

Chief Financial Officer

 

30,147

 

Suzanne Smith

Chief Legal Officer and Company Secretary

10,100

 

* The award made to Alan Hirzel is in the form of conditional shares which will be transferred following vesting.

The Awards will vest in three years' time subject to continued employment and satisfaction of performance conditions. The performance conditions are split 70% on the growth in earnings per share and 30% on strategic KPIs, as detailed in the Company's annual report.

Additional post-vesting holding periods of 3 years and 2 years will apply to the Awards for Alan Hirzel and Gavin Wood respectively.

The notifications for these Awards can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

 

For further information, please contact:

Abcam

+ 44 (0) 1223 696 000

 

Suzanne Smith, Company Secretary

 

 

J.P.Morgan Cazenove - Nominated Advisor & Corporate Broker

+ 44 (0) 20 7742 4000

 

James Mitford / Candelle Chong

 

FTI Consulting

+ 44 (0) 20 3727 1000

 

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Alan Hirzel

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Grant of conditional shares under the Abcam plc Long Term Incentive Plan ("LTIP"):

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

60,294

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

60,294

Nil

Nil

f)

Date of the transaction

3 November 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Gavin Wood

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Grant of nil cost options under the Abcam plc Long Term Incentive Plan ("LTIP"):

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

0.2p

30,147

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

30,147

0.2 pence per share

£60.29

f)

Date of the transaction

3 November 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mrs Suzanne Smith

2

Reason for the notification

a)

Position/status

Chief Legal Officer and Company Secretary

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Grant of nil cost options under the Abcam plc Long Term Incentive Plan ("LTIP"):

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

0.2p

10,100

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

10,100

0.2 pence per share

£20.20

f)

Date of the transaction

3 November 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHQQLFBDFFZFBQ
Date   Source Headline
9th Dec 20162:56 pmRNSDirector/PDMR Shareholding
8th Dec 20165:09 pmRNSDirector/PDMR Shareholding
5th Dec 20162:45 pmRNSDirector/PDMR Shareholding
1st Dec 20164:01 pmRNSTotal Voting Rights
10th Nov 20162:00 pmRNSApplication for admission to trading
10th Nov 20167:00 amRNSAxioMx technology milestones accelerated
7th Nov 201611:21 amRNSDirector/PDMR Shareholding
7th Nov 20169:30 amRNSDirector/PDMR Shareholding
2nd Nov 20164:22 pmRNSResult of AGM
2nd Nov 20167:00 amRNSAGM Statement
1st Nov 20163:02 pmRNSTotal Voting Rights
27th Oct 20167:00 amRNSDirector/PDMR Shareholding
24th Oct 20167:00 amRNSNew facility at Cambridge Biomedical Campus
3rd Oct 20161:07 pmRNSTotal Voting Rights
3rd Oct 20167:00 amRNSDirector/PDMR Shareholding
28th Sep 20168:43 amRNSDirector/PDMR Shareholding
26th Sep 20167:19 amRNSAnnual Financial Report
21st Sep 20167:00 amRNSDirector/PDMR Shareholding
21st Sep 20167:00 amRNSHolding(s) in Company
15th Sep 20162:25 pmRNSDirector/PDMR Shareholding
12th Sep 20167:00 amRNSPreliminary Results
2nd Sep 20167:00 amRNSApplication for admission to trading
24th Aug 20167:00 amRNSNotice of Results
23rd Aug 20163:01 pmRNSBlock listing Interim Review
3rd Aug 20167:00 amRNSDirectorate Change
1st Aug 20161:11 pmRNSTotal Voting Rights
25th Jul 20167:00 amRNSPre-Close Period Update
1st Jul 20162:12 pmRNSTotal Voting Rights
20th Jun 20167:00 amRNSAbcam to appoint Gavin Wood as CFO
1st Jun 20164:38 pmRNSTotal Voting Rights
3rd May 20162:03 pmRNSTotal Voting Rights
19th Apr 20162:35 pmRNSDirector/PDMR Shareholding
1st Apr 20161:50 pmRNSTotal Voting Rights
24th Mar 20162:29 pmRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSPosting of Half Yearly Report
22nd Mar 20169:33 amRNSDirector/PDMR Shareholding
7th Mar 20167:00 amRNSDirectorate Change
7th Mar 20167:00 amRNSHalf Yearly Report
10th Feb 201610:59 amRNSNotice of Results
8th Feb 20163:58 pmRNSBlocklisting Interim Review
1st Feb 20162:06 pmRNSTotal Voting Rights
29th Jan 20163:09 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSHalf Year Trading Update
4th Jan 20163:02 pmRNSTotal Voting Rights
7th Dec 20153:57 pmRNSDirector/PDMR Shareholding
7th Dec 20151:59 pmRNSDirector/PDMR Shareholding
1st Dec 20154:30 pmRNSTotal Voting Rights
12th Nov 20153:22 pmRNSApplication for admission to trading - update
12th Nov 20152:56 pmRNSDirector/PDMR Shareholding
11th Nov 20154:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.